Literature DB >> 8377373

Proliferative autoimmune glomerulonephritis in rats: a model for autoimmune glomerulonephritis in humans.

W K Bolton1, W J May, B C Sturgill.   

Abstract

Some forms of glomerulonephritis (GN) in humans appear consequent to autoimmunity. Experimental autoimmune GN (EAG) has been described in sheep, but attempts to develop EAG in other mammals have resulted only in antibody and proteinuria but no GN. We have developed a model of EAG in an inbred mammalian species to further study pathogenetic mechanisms. We immunized Brown Norway (BN) and Wistar-Kyoto (WKY) rats with glomerular basement membrane (GBM) or collagenase solubilized GBM (csGBM). Circulating and bound anti-GBM antibody developed in all rats. Only interstitial nephritis occurred in BN rats despite amounts of glomerular and serum anti GBM antibodies similar to WKY animals. One hundred percent of WKY rats immunized with csGBM/acid developed reproducible severe GN at two to three weeks with proteinuria and decreased kidney function which progressed to glomerulosclerosis and interstitial fibrosis. Antigen in acid was a requisite for induction of EAG. EAG rats had positive tests for delayed type hypersensitivity, their T cells underwent antigen specific transformation, and T cells and macrophages were present histologically. Passive transfer of EAG serum to naive rats resulted in fixation to recipient GBM but no proteinuria or GN. This new model of EAG in rats appears dependent on genetic factors, may involve cellular immunity in pathogenesis, requires exposure of the nephritogenic antigen, and is highly similar to rapidly progressive GN in humans.

Entities:  

Mesh:

Year:  1993        PMID: 8377373     DOI: 10.1038/ki.1993.244

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  What sensitized cells just might be doing in glomerulonephritis.

Authors:  W Kline Bolton
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.

Authors:  Vadim Pedchenko; Roberto Vanacore; Billy Hudson
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

Review 3.  Strain differences and the genetic basis of experimental autoimmune anti-glomerular basement membrane glomerulonephritis.

Authors:  John Reynolds
Journal:  Int J Exp Pathol       Date:  2011-02-23       Impact factor: 1.925

4.  CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; F W Tam; A Chandraker; J Smith; A M Karkar; J Cross; R Peach; M H Sayegh; C D Pusey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Molecular mapping of the Goodpasture's epitope for glomerulonephritis.

Authors:  W Kline Bolton; Lanlin Chen; Thomas Hellmark; Jay Fox; Jorgen Wieslander
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

6.  Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.

Authors:  Zhao Cui; Ming-Hui Zhao; Xiao-Yu Jia; Miao Wang; Shui-Yi Hu; Su-Xia Wang; Feng Yu; Kyle L Brown; Billy G Hudson; Vadim Pedchenko
Journal:  J Autoimmun       Date:  2016-04-23       Impact factor: 7.094

7.  Analysis of T cell responses to the autoantigen in Goodpasture's disease.

Authors:  C J Derry; C N Ross; G Lombardi; P D Mason; A J Rees; R I Lechler; C D Pusey
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 8.  T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop.

Authors:  Sun-Sang Sung; Warren K Bolton
Journal:  Kidney Int       Date:  2009-12-23       Impact factor: 10.612

9.  Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.

Authors:  John Reynolds; Paul R Cook; Jacques Behmoaras; Jennifer Smith; Gurjeet Bhangal; Susan Tadros; Jonathan Tee; Alan D Salama; David J Evans; Timothy J Aitman; H Terence Cook; Charles D Pusey
Journal:  Am J Pathol       Date:  2012-03-22       Impact factor: 4.307

10.  Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.

Authors:  Paul E Gray; Hugh McCarthy; Owen M Siggs; Moin A Saleem; Tracy O' Brien; Katie Frith; John B Ziegler; A Richard Kitching; Agnes B Fogo; Billy G Hudson; Vadim Pedchenko
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.